full year 2022 financial results

Wednesday February 8 

 

Conference call at 13.00 CET / 7AM EST 

 

To participate, please use the following dial ins:

DK: +45 78768490

UK: +44 2037696819

US: +1 6467870157 

 

PIN: 930586

This is Lundbeck

We are one of the only pharmaceutical companies in the world focusing exclusively on brain diseases, and we’re set apart by our specialization. 

With more than 70 years of neuroscience expertise, Lundbeck has developed and commercialized some of the world's most widely prescribed therapies for brain diseases.

Come join us in making a difference to patients worldwide.

Explore the latest financial developments at Lundbeck.

a better life for people with brain diseases

At Lundbeck, we see patients as people and are committed to support the person behind the disease. 

Partnering

The complexity of brain diseases requires a concerted effort. We are committed to develop new and better treatment options from innovations born in house or externally.

Mara Formentini on working at Lundbeck

Bringing Your Whole Self to Work and its Rewards

Lundbeck at a glance

100

countries where our products are sold

5,300

employees supporting our purpose

1915

year Lundbeck was founded